DIAGNOSEX Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for DIAGNOSEX with the United States Patent and Trademark Office. The USPTO has given the DIAGNOSEX trademark a serial number of 98417208. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 22, 2024. This trademark is owned by DIAGNOSEX,INC.. The DIAGNOSEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of mRNA drugs; Research and development of siRNA drugs
diagnosex

General Information


Serial Number98417208
Word MarkDIAGNOSEX
Filing DateThursday, February 22, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, February 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of DIAGNOSEX means try all the best to find or explore new testing and medications for humans diseases all over the world!.
Indication of Colors claimedThe color(s) Yellow pink blue is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of mRNA drugs; Research and development of siRNA drugs

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDIAGNOSEX,INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024NEW APPLICATION ENTERED
Saturday, June 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED